Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 1/2022

01-02-2022 | Dementia | Original Article

Altered mental status is an independent predictor of mortality in hospitalized COVID-19 patients

Authors: Marjorie J. Kenerly, Priyank Shah, Hiten Patel, Rilee Racine, Yash Jani, Caroline Owens, Varghese George, Daniel Linder, Jack Owens, David C. Hess

Published in: Irish Journal of Medical Science (1971 -) | Issue 1/2022

Login to get access

Abstract

Background/aims

Limited data exists on the outcomes of COVID-19 patients presenting with altered mental status (AMS). Hence, we studied the characteristics and outcomes of hospitalized COVID-19 patients who presented with AMS at our hospital in rural southwest Georgia.

Methods

Data from electronic medical records of all hospitalized COVID-19 patients from March 2, 2020, to June 17, 2020, were analyzed. Patients were divided in 2 groups, those presenting with and without AMS. Primary outcome of interest was in-hospital mortality. Secondary outcomes were needed for mechanical ventilation, need for intensive care unit (ICU) care, need for dialysis, and length of stay. All analyses were performed using SAS 9.4 and R 3.6.0.

Results

Out of 710 patients, 73 (10.3%) presented with AMS. Majority of the population was African American (83.4%). Patients with AMS were older and more likely to have hypertension, chronic kidney disease (CKD), cerebrovascular disease, and dementia. Patients with AMS were less likely to present with typical COVID-19 symptoms, including dyspnea, cough, fever, and gastrointestinal symptoms. Predictors of AMS included age ≥ 70 years, CKD, cerebrovascular disease, and dementia. After multivariable adjustment, patients with AMS had higher rates of in-hospital mortality (30.1% vs 14.8%, odds ratio (OR) 2.139, p = 0.019), ICU admission (43.8% vs 40.2%, OR 2.59, p < 0.001), and need for mechanical ventilation (27.4% vs 18.5%, OR 2.06, p = 0.023). Patients presenting with AMS had increased length of stay.

Conclusions

Patients with COVID-19 presenting with AMS are less likely to have typical COVID-19 symptoms, and AMS is an independent predictor of in-hospital mortality, need for ICU admission, and need for mechanical ventilation.
Literature
2.
go back to reference Wu Y, Xu X, Chen Z et al (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 87:18–22CrossRef Wu Y, Xu X, Chen Z et al (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 87:18–22CrossRef
3.
go back to reference Chachkhiani D, Soliman MY, Barua D et al (2020) Neurological complications in a predominantly African American sample of COVID-19 predict worse outcomes during hospitalization [published online ahead of print, 2020 Aug 25]. Clin Neurol Neurosurg 197:106173 Chachkhiani D, Soliman MY, Barua D et al (2020) Neurological complications in a predominantly African American sample of COVID-19 predict worse outcomes during hospitalization [published online ahead of print, 2020 Aug 25]. Clin Neurol Neurosurg 197:106173
7.
go back to reference Mao L, Jin H, Wang M et al (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan. China JAMA Neurol 77(6):683–690CrossRef Mao L, Jin H, Wang M et al (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan. China JAMA Neurol 77(6):683–690CrossRef
Metadata
Title
Altered mental status is an independent predictor of mortality in hospitalized COVID-19 patients
Authors
Marjorie J. Kenerly
Priyank Shah
Hiten Patel
Rilee Racine
Yash Jani
Caroline Owens
Varghese George
Daniel Linder
Jack Owens
David C. Hess
Publication date
01-02-2022
Publisher
Springer International Publishing
Published in
Irish Journal of Medical Science (1971 -) / Issue 1/2022
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-021-02515-4

Other articles of this Issue 1/2022

Irish Journal of Medical Science (1971 -) 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.